GNI Group Ltd
TSE:2160

Watchlist Manager
GNI Group Ltd Logo
GNI Group Ltd
TSE:2160
Watchlist
Price: 2 814 JPY -1.26% Market Closed
Market Cap: 140.9B JPY
Have any thoughts about
GNI Group Ltd?
Write Note
GNI Group Ltd
/
Balance Sheet
/
PP&E Net

GNI Group Ltd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GNI Group Ltd
PP&E Net Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
GNI Group Ltd
TSE:2160
PP&E Net
¥6.9B
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
40%
PeptiDream Inc
TSE:4587
PP&E Net
¥17.2B
CAGR 3-Years
39%
CAGR 5-Years
24%
CAGR 10-Years
59%
Takara Bio Inc
TSE:4974
PP&E Net
¥50.1B
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
11%
Pharma Foods International Co Ltd
TSE:2929
PP&E Net
¥4.6B
CAGR 3-Years
37%
CAGR 5-Years
37%
CAGR 10-Years
21%
S
StemRIM Inc
TSE:4599
PP&E Net
¥185.8m
CAGR 3-Years
-17%
CAGR 5-Years
80%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
PP&E Net
¥514.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GNI Group Ltd
Glance View

Market Cap
140.9B JPY
Industry
Biotechnology

GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 629 full-time employees. The company went IPO on 2007-08-31. The firm is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. The company is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for liver fibrosis (cirrhosis) and F573 for acute hepatic insufficiency and acute chronic liver failure (ACLF).

Intrinsic Value
4 144.85 JPY
Undervaluation 32%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is GNI Group Ltd's PP&E Net?
PP&E Net
6.9B JPY

Based on the financial report for Jun 30, 2024, GNI Group Ltd's PP&E Net amounts to 6.9B JPY.

What is GNI Group Ltd's PP&E Net growth rate?
PP&E Net CAGR 10Y
40%

Over the last year, the PP&E Net growth was 28%. The average annual PP&E Net growth rates for GNI Group Ltd have been 27% over the past three years , 23% over the past five years , and 40% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.